Quaker Chemical shareholders elect directors and approve executive compensation at 2023 annual meeting

The Company’s shareholders indicated their preference, on a non-binding basis, that the advisory vote on executive compensation be held every year. The Board of Directors of the Company (the “Board”) had recommended that the advisory vote on executive compensation be held every three years. The results of the vote were as follows: 1 Year 2 Years 3 Years Abstain Broker Non-Votes 11,861,009 60,357 4,508,887 440,059 380,670

The shareholders voted to ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year 2023. The results of the vote were as follows: For Against Abstain 17,076,547 163,716 10,719

The shareholders voted to approve the 2023 Director Stock Ownership Plan (the “Plan”) as described in and as included as an appendix to the 2023 Proxy Statement. The results of the vote were as follows: For Against Abstain Broker Non-Votes 16,791,991 61,117 17,204 380,670

The shareholders elected three directors to serve a three-year term until the 2026 annual meeting of shareholders and until their respective successors are duly elected and qualified. The results of the vote were as follows: Directors For Against Abstain Broker Non-Votes Charlotte C. Decker 12,904,987 3,939,238 26,087 380,670 Ramaswami Seshasayee 14,977,257 1,866,138 26,917 380,670 Andrew E. Tometich 15,159,570 1,690,557 20,185 380,670

The Company’s shareholders approved, on a non-binding basis, the Company’s compensation of its named executive officers as described in the Compensation Discussion and Analysis section and the accompanying compensation tables and narrative disclosures contained in the Company’s Proxy Statement for the 2023 Annual Meeting (the “2023 Proxy Statement”). The results of the vote were as follows: For Against Abstain Broker Non-Votes 16,304,939 552,557 12,816 380,670